 | • レポートコード：MRC2Q12-18870 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、塩基性輸液のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 塩基性輸液のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 塩基性輸液の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 塩基性輸液のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの塩基性輸液の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の塩基性輸液の売上および2028年までの予測に焦点を当てています。 塩基性輸液のグローバル主要企業には、Baxter、B. Braun、Fresenius Kabi、Kelun Pharma、Otsuka Pharmaceutical、JW Pharmaceutical、Pfizer、Teva Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy、Grand Life Sciences、Medisan、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical、Lionco Pharmaceutical、China Meheco Kangliなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 塩基性輸液市場は、タイプとアプリケーションによって区分されます。世界の塩基性輸液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ブドウ糖、塩化ナトリウム、化合物 【アプリケーション別セグメント】 最大100ml、250ml、500ml、最初1L 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 塩基性輸液製品概要 - タイプ別市場（ブドウ糖、塩化ナトリウム、化合物） - アプリケーション別市場（最大100ml、250ml、500ml、最初1L） - 調査の目的 ・エグゼクティブサマリー - 世界の塩基性輸液販売量予測2017-2028 - 世界の塩基性輸液売上予測2017-2028 - 塩基性輸液の地域別販売量 - 塩基性輸液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別塩基性輸液販売量 - 主要メーカー別塩基性輸液売上 - 主要メーカー別塩基性輸液価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ブドウ糖、塩化ナトリウム、化合物） - 塩基性輸液のタイプ別販売量 - 塩基性輸液のタイプ別売上 - 塩基性輸液のタイプ別価格 ・アプリケーション別市場規模（最大100ml、250ml、500ml、最初1L） - 塩基性輸液のアプリケーション別販売量 - 塩基性輸液のアプリケーション別売上 - 塩基性輸液のアプリケーション別価格 ・北米市場 - 北米の塩基性輸液市場規模（タイプ別、アプリケーション別） - 主要国別の塩基性輸液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの塩基性輸液市場規模（タイプ別、アプリケーション別） - 主要国別の塩基性輸液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の塩基性輸液市場規模（タイプ別、アプリケーション別） - 主要国別の塩基性輸液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の塩基性輸液市場規模（タイプ別、アプリケーション別） - 主要国別の塩基性輸液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの塩基性輸液市場規模（タイプ別、アプリケーション別） - 主要国別の塩基性輸液市場規模（トルコ、サウジアラビア） ・企業情報 Baxter、B. Braun、Fresenius Kabi、Kelun Pharma、Otsuka Pharmaceutical、JW Pharmaceutical、Pfizer、Teva Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy、Grand Life Sciences、Medisan、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical、Lionco Pharmaceutical、China Meheco Kangli ・産業チェーン及び販売チャネル分析 - 塩基性輸液の産業チェーン分析 - 塩基性輸液の原材料 - 塩基性輸液の生産プロセス - 塩基性輸液の販売及びマーケティング - 塩基性輸液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 塩基性輸液の産業動向 - 塩基性輸液のマーケットドライバー - 塩基性輸液の課題 - 塩基性輸液の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Basic Infusion Market
Due to the COVID-19 pandemic, the global Basic Infusion market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Glucose accounting for % of the Basic Infusion global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While max. 100ml segment is altered to an % CAGR throughout this forecast period.
China Basic Infusion market size is valued at US$ million in 2021, while the US and Europe Basic Infusion are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Basic Infusion landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Basic Infusion include Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical and Haisco Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Basic Infusion Scope and Segment
Basic Infusion market is segmented by Type and by Packaging. Players, stakeholders, and other participants in the global Basic Infusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Packaging for the period 2017-2028.
Segment by Type
Glucose
Sodium Chloride
Compound Product
Segment by Packaging
max. 100ml
250ml
500ml
min. 1L
By Company
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Basic Infusion Product Introduction
1.2 Market by Type
1.2.1 Global Basic Infusion Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glucose
1.2.3 Sodium Chloride
1.2.4 Compound Product
1.3 Market by Packaging
1.3.1 Global Basic Infusion Market Size Growth Rate by Packaging, 2017 VS 2021 VS 2028
1.3.2 max. 100ml
1.3.3 250ml
1.3.4 500ml
1.3.5 min. 1L
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Basic Infusion Sales Estimates and Forecasts 2017-2028
2.2 Global Basic Infusion Revenue Estimates and Forecasts 2017-2028
2.3 Global Basic Infusion Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Basic Infusion Sales by Region
2.4.1 Global Basic Infusion Sales by Region (2017-2022)
2.4.2 Global Sales Basic Infusion by Region (2023-2028)
2.5 Global Basic Infusion Revenue by Region
2.5.1 Global Basic Infusion Revenue by Region (2017-2022)
2.5.2 Global Basic Infusion Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Basic Infusion Sales by Manufacturers
3.1.1 Global Top Basic Infusion Manufacturers by Sales (2017-2022)
3.1.2 Global Basic Infusion Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Basic Infusion in 2021
3.2 Global Basic Infusion Revenue by Manufacturers
3.2.1 Global Basic Infusion Revenue by Manufacturers (2017-2022)
3.2.2 Global Basic Infusion Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Basic Infusion Revenue in 2021
3.3 Global Basic Infusion Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Basic Infusion Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Basic Infusion Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Basic Infusion Sales by Type
4.1.1 Global Basic Infusion Historical Sales by Type (2017-2022)
4.1.2 Global Basic Infusion Forecasted Sales by Type (2023-2028)
4.1.3 Global Basic Infusion Sales Market Share by Type (2017-2028)
4.2 Global Basic Infusion Revenue by Type
4.2.1 Global Basic Infusion Historical Revenue by Type (2017-2022)
4.2.2 Global Basic Infusion Forecasted Revenue by Type (2023-2028)
4.2.3 Global Basic Infusion Revenue Market Share by Type (2017-2028)
4.3 Global Basic Infusion Price by Type
4.3.1 Global Basic Infusion Price by Type (2017-2022)
4.3.2 Global Basic Infusion Price Forecast by Type (2023-2028)
5 Market Size by Packaging
5.1 Global Basic Infusion Sales by Packaging
5.1.1 Global Basic Infusion Historical Sales by Packaging (2017-2022)
5.1.2 Global Basic Infusion Forecasted Sales by Packaging (2023-2028)
5.1.3 Global Basic Infusion Sales Market Share by Packaging (2017-2028)
5.2 Global Basic Infusion Revenue by Packaging
5.2.1 Global Basic Infusion Historical Revenue by Packaging (2017-2022)
5.2.2 Global Basic Infusion Forecasted Revenue by Packaging (2023-2028)
5.2.3 Global Basic Infusion Revenue Market Share by Packaging (2017-2028)
5.3 Global Basic Infusion Price by Packaging
5.3.1 Global Basic Infusion Price by Packaging (2017-2022)
5.3.2 Global Basic Infusion Price Forecast by Packaging (2023-2028)
6 North America
6.1 North America Basic Infusion Market Size by Type
6.1.1 North America Basic Infusion Sales by Type (2017-2028)
6.1.2 North America Basic Infusion Revenue by Type (2017-2028)
6.2 North America Basic Infusion Market Size by Packaging
6.2.1 North America Basic Infusion Sales by Packaging (2017-2028)
6.2.2 North America Basic Infusion Revenue by Packaging (2017-2028)
6.3 North America Basic Infusion Market Size by Country
6.3.1 North America Basic Infusion Sales by Country (2017-2028)
6.3.2 North America Basic Infusion Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Basic Infusion Market Size by Type
7.1.1 Europe Basic Infusion Sales by Type (2017-2028)
7.1.2 Europe Basic Infusion Revenue by Type (2017-2028)
7.2 Europe Basic Infusion Market Size by Packaging
7.2.1 Europe Basic Infusion Sales by Packaging (2017-2028)
7.2.2 Europe Basic Infusion Revenue by Packaging (2017-2028)
7.3 Europe Basic Infusion Market Size by Country
7.3.1 Europe Basic Infusion Sales by Country (2017-2028)
7.3.2 Europe Basic Infusion Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Basic Infusion Market Size by Type
8.1.1 Asia Pacific Basic Infusion Sales by Type (2017-2028)
8.1.2 Asia Pacific Basic Infusion Revenue by Type (2017-2028)
8.2 Asia Pacific Basic Infusion Market Size by Packaging
8.2.1 Asia Pacific Basic Infusion Sales by Packaging (2017-2028)
8.2.2 Asia Pacific Basic Infusion Revenue by Packaging (2017-2028)
8.3 Asia Pacific Basic Infusion Market Size by Region
8.3.1 Asia Pacific Basic Infusion Sales by Region (2017-2028)
8.3.2 Asia Pacific Basic Infusion Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Basic Infusion Market Size by Type
9.1.1 Latin America Basic Infusion Sales by Type (2017-2028)
9.1.2 Latin America Basic Infusion Revenue by Type (2017-2028)
9.2 Latin America Basic Infusion Market Size by Packaging
9.2.1 Latin America Basic Infusion Sales by Packaging (2017-2028)
9.2.2 Latin America Basic Infusion Revenue by Packaging (2017-2028)
9.3 Latin America Basic Infusion Market Size by Country
9.3.1 Latin America Basic Infusion Sales by Country (2017-2028)
9.3.2 Latin America Basic Infusion Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Basic Infusion Market Size by Type
10.1.1 Middle East and Africa Basic Infusion Sales by Type (2017-2028)
10.1.2 Middle East and Africa Basic Infusion Revenue by Type (2017-2028)
10.2 Middle East and Africa Basic Infusion Market Size by Packaging
10.2.1 Middle East and Africa Basic Infusion Sales by Packaging (2017-2028)
10.2.2 Middle East and Africa Basic Infusion Revenue by Packaging (2017-2028)
10.3 Middle East and Africa Basic Infusion Market Size by Country
10.3.1 Middle East and Africa Basic Infusion Sales by Country (2017-2028)
10.3.2 Middle East and Africa Basic Infusion Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Overview
11.1.3 Baxter Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Baxter Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Overview
11.2.3 B. Braun Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 B. Braun Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 B. Braun Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Corporation Information
11.3.2 Fresenius Kabi Overview
11.3.3 Fresenius Kabi Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fresenius Kabi Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fresenius Kabi Recent Developments
11.4 Kelun Pharma
11.4.1 Kelun Pharma Corporation Information
11.4.2 Kelun Pharma Overview
11.4.3 Kelun Pharma Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kelun Pharma Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kelun Pharma Recent Developments
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Corporation Information
11.5.2 Otsuka Pharmaceutical Overview
11.5.3 Otsuka Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Otsuka Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Otsuka Pharmaceutical Recent Developments
11.6 JW Pharmaceutical
11.6.1 JW Pharmaceutical Corporation Information
11.6.2 JW Pharmaceutical Overview
11.6.3 JW Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 JW Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 JW Pharmaceutical Recent Developments
11.7 Pfizer
11.7.1 Pfizer Corporation Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Pfizer Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Corporation Information
11.8.2 Teva Pharmaceutical Overview
11.8.3 Teva Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Haisco Pharmaceutical Group
11.9.1 Haisco Pharmaceutical Group Corporation Information
11.9.2 Haisco Pharmaceutical Group Overview
11.9.3 Haisco Pharmaceutical Group Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Haisco Pharmaceutical Group Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Haisco Pharmaceutical Group Recent Developments
11.10 King York
11.10.1 King York Corporation Information
11.10.2 King York Overview
11.10.3 King York Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 King York Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 King York Recent Developments
11.11 Cisen
11.11.1 Cisen Corporation Information
11.11.2 Cisen Overview
11.11.3 Cisen Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Cisen Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Cisen Recent Developments
11.12 Lummy
11.12.1 Lummy Corporation Information
11.12.2 Lummy Overview
11.12.3 Lummy Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Lummy Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Lummy Recent Developments
11.13 Grand Life Sciences
11.13.1 Grand Life Sciences Corporation Information
11.13.2 Grand Life Sciences Overview
11.13.3 Grand Life Sciences Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Grand Life Sciences Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Grand Life Sciences Recent Developments
11.14 Medisan
11.14.1 Medisan Corporation Information
11.14.2 Medisan Overview
11.14.3 Medisan Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Medisan Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Medisan Recent Developments
11.15 BBCA Pharmaceutical
11.15.1 BBCA Pharmaceutical Corporation Information
11.15.2 BBCA Pharmaceutical Overview
11.15.3 BBCA Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 BBCA Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 BBCA Pharmaceutical Recent Developments
11.16 Biokin Pharmaceutical
11.16.1 Biokin Pharmaceutical Corporation Information
11.16.2 Biokin Pharmaceutical Overview
11.16.3 Biokin Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Biokin Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Biokin Pharmaceutical Recent Developments
11.17 Xi’an Libang Pharmaceutical
11.17.1 Xi’an Libang Pharmaceutical Corporation Information
11.17.2 Xi’an Libang Pharmaceutical Overview
11.17.3 Xi’an Libang Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Xi’an Libang Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Xi’an Libang Pharmaceutical Recent Developments
11.18 Lionco Pharmaceutical
11.18.1 Lionco Pharmaceutical Corporation Information
11.18.2 Lionco Pharmaceutical Overview
11.18.3 Lionco Pharmaceutical Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Lionco Pharmaceutical Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Lionco Pharmaceutical Recent Developments
11.19 China Meheco Kangli
11.19.1 China Meheco Kangli Corporation Information
11.19.2 China Meheco Kangli Overview
11.19.3 China Meheco Kangli Basic Infusion Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 China Meheco Kangli Basic Infusion Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 China Meheco Kangli Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Basic Infusion Industry Chain Analysis
12.2 Basic Infusion Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Basic Infusion Production Mode & Process
12.4 Basic Infusion Sales and Marketing
12.4.1 Basic Infusion Sales Channels
12.4.2 Basic Infusion Distributors
12.5 Basic Infusion Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Basic Infusion Industry Trends
13.2 Basic Infusion Market Drivers
13.3 Basic Infusion Market Challenges
13.4 Basic Infusion Market Restraints
14 Key Findings in The Global Basic Infusion Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer